| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |